Johnson & Johnson
JNJ
$167.33
$2.591.57%
NYSE
| 06/29/2025 | 03/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.45% | -2.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.45% | -2.78% | |||
| Cost of Revenue | 5.02% | 4.94% | |||
| Gross Profit | 10.15% | -6.20% | |||
| SG&A Expenses | 15.48% | -20.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.62% | -16.15% | |||
| Operating Income | 5.65% | 57.49% | |||
| Income Before Tax | -52.38% | 250.68% | |||
| Income Tax Expenses | -63.75% | 477.19% | |||
| Earnings from Continuing Operations | -49.66% | 220.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -49.66% | 220.58% | |||
| EBIT | 5.65% | 57.49% | |||
| EBITDA | 6.52% | 37.20% | |||
| EPS Basic | -49.64% | 223.23% | |||
| Normalized Basic EPS | -0.52% | 65.67% | |||
| EPS Diluted | -49.56% | 221.71% | |||
| Normalized Diluted EPS | -0.37% | 64.55% | |||
| Average Basic Shares Outstanding | -0.04% | -0.82% | |||
| Average Diluted Shares Outstanding | -0.19% | -0.14% | |||
| Dividend Per Share | 4.84% | 0.00% | |||
| Payout Ratio | 1.08% | -0.69% | |||